Citations

Showing 10 of 108152 citations.

Sex Differences in the Use of Statins in Community Practice
Wang, Tracy Y., Xiang, Qun, Goldberg, Anne C. , Robinson, Jennifer G. , Roger, Véronique L. , Louie, Michael J. , Koren, Andrew , Li, Zhuokai , Nanna, Michael G. , Virani, Salim S. , Wilson, Peter W.F. , Peterson, Eric D. , Návar, Ann Marie

Mayo Clinic

Circulation: Cardiovascular Quality and Outcomes | August 16, 2019 | Volume: 12 | Issue: 8 | Pages: No page available

10.1161/circoutcomes.118.005562 | PMID 31416347 Get It

Background: Female patients have historically received less aggressive lipid management than male patients. Contemporary care patterns and the potential causes for these differences are unknown. Methods and Results: Examining the Patient and Provider Assessment of Lipid Management Registry—a nationwide registry of outpatients with or at risk for atherosclerotic cardiovascular disease—we compared the use of statin therapy, guideline-recommended statin dosing, and reasons for undertreatment. We specifically analyzed sex differences in statin treatment and guideline-recommended statin dosing using multivariable logistic regression. Among 5693 participants (43% women) eligible for 2013 American College of Cardiology/American Heart Association Cholesterol Guideline–recommended statin treatment, women were less likely than men to be prescribed any statin therapy (67.0% versus 78.4%; P <0.001) or to receive a statin at the guideline-recommended intensity (36.7% versus 45.2%; P <0.001). Women were more likely to report having previously never been offered statin therapy (18.6% versus 13.5%; P <0.001), declined statin therapy (3.6% versus 2.0%; P <0.001), or discontinued their statin (10.9% versus 6.1%; P <0.001). Women were also less likely than men to believe statins were safe (47.9% versus 55.2%; P <0.001) or effective (68.0% versus 73.2%; P <0.001) and more likely to report discontinuing their statin because of a side effect (7.9% versus 3.6%; P <0.001). Sex differences in both overall and guideline-recommended intensity statin use persisted after adjustment for demographics, socioeconomic factors, clinical characteristics, patient beliefs, and provider characteristics (adjusted odds ratio, 0.70; 95% CI, 0.61–0.81; P <0.001; and odds ratio, 0.82; 95% CI, 0.73–0.92; P <0.01, respectively). Sex differences were consistent across primary and secondary prevention indications for statin treatment. Conclusions: Women eligible for statin therapy were less likely than men to be treated with any statin or guideline-recommended statin intensity. A combination of women being offered statin therapy less frequently, while declining and discontinuing treatment more frequently, accounted for these sex differences in statin use.
RAB8, RAB10 and RILPL1 contribute to both LRRK2 kinase–mediated centrosomal cohesion and ciliogenesis deficits
Ordóñez, Antonio Jesús Lara , Fernández, Belén , Fdez, Elena , Romo-Lozano, María , Madero‐Pérez, Jesús , Lobbestael, Evy , Aiastui, Ana , Munaín, Adolfo López de , Melrose, Heather L. , Civiero, Laura , Hilfiker, Sabine , Baekelandt, Veerle

Mayo Clinic

Human Molecular Genetics | August 15, 2019 | Volume: 28 | Issue: 21 | Pages: 3552-3568

10.1093/hmg/ddz201 | PMID 31428781 Get It

AbstractMutations in the LRRK2 kinase are the most common cause of familial Parkinson’s disease, and variants increase risk for the sporadic form of the disease. LRRK2 phosphorylates multiple RAB GTPases including RAB8A and RAB10. Phosphorylated RAB10 is recruited to centrosome-localized RILPL1, which may interfere with ciliogenesis in a disease-relevant context. Our previous studies indicate that the centrosomal accumulation of phosphorylated RAB8A causes centrosomal cohesion deficits in dividing cells, including in peripheral patient-derived cells. Here, we show that both RAB8 and RAB10 contribute to the centrosomal cohesion deficits. Pathogenic LRRK2 causes the centrosomal accumulation not only of phosho-RAB8 but also of phospho-RAB10, and the effects on centrosomal cohesion are dependent on RAB8, RAB10 and RILPL1. Conversely, the pathogenic LRRK2-mediated ciliogenesis defects correlate with the centrosomal accumulation of both phospho-RAB8 and phospho-RAB10. LRRK2-mediated centrosomal cohesion and ciliogenesis alterations are observed in patient-derived peripheral cells, as well as in primary astrocytes from mutant LRRK2 mice, and are reverted upon LRRK2 kinase inhibition. These data suggest that the LRRK2-mediated centrosomal cohesion and ciliogenesis defects are distinct cellular readouts of the same underlying phospho-RAB8/RAB10/RILPL1 nexus and highlight the possibility that either centrosomal cohesion and/or ciliogenesis alterations may serve as cellular biomarkers for LRRK2-related PD.
Volvulus of the ileal pouch–anal anastomosis: a meta-narrative systematic review of frequency, diagnosis, and treatment outcomes
Jawoosh, Muhammad , Haffar, Samir , Deepak, Parakkal , Meyer, Alyssa J. , Raffals, Laura H., Murad, M. Hassan , Buttar, Navtej , Bazerbachi, Fateh , Meyers, Alyssa, Bazerbachi, F , Murad, M Hassan , Deepak, Parakkal , Lightner, Amy L. , Larson, David W.

Mayo Clinic

Gastroenterology Report | August 15, 2019 | Volume: 7 | Issue: 6 | Pages: 403-410

10.1093/gastro/goz045 | PMID 31857902 Get It

Abstract Background Proctocolectomy with ileal pouch–anal anastomosis (IPAA) is the surgical procedure of choice for medically refractory ulcerative colitis and familial adenomatous polyposis. While rare, a pouch volvulus can occur. We aimed to determine the frequency, presentation, and management approach of pouch volvulus in patients with IPAA. Methods A systematic search of published literature was performed by a medical reference librarian on 10 August 2018 and two independent reviewers identified relevant publications, extracted data, and assessed the methodological quality based on a validated tool. A retrospective review of the Mayo Clinic electronic medical records identified one case of pouch volvulus between January 2008 and August 2018. Results The frequency of pouch volvulus from one large published study reporting long-term outcomes of IPAA was 0.18% (3/1,700). A total of 22 patients (18 ulcerative colitis) were included (median age 32 years, 73% females). Median time to volvulus after IPAA was 36 months while median interval to volvulus diagnosis from symptom onset was 24 hours. Abdominal pain was the most commonly reported symptom (76%). The diagnosis was made primarily by abdominal computed tomography (13/17 patients, 76%). Endoscopic treatment was successful in 1 of 11 patients (9%). Surgery was performed in 20 patients and pouch-pexy and pouch excision were the most frequent surgical operations. A redo IPAA was performed in five patients (25%). Conclusion Pouch volvulus is a rare but serious complication of IPAA and should be suspected even in the absence of obstruction symptoms. Endoscopic treatment often fails and surgery is effective when performed early.
Mentorship: A Pathway to Succeed in Plastic Surgery
Huayllani, María T. , Restrepo, David J. , Rinker, Brian, Forte, Antonio J. , Boczar, Daniel , Rinker, Brian D, Forte, Antonio Jorge , Sisti, Andrea , Nisi, Giuseppe

Mayo Clinic

Plastic & Reconstructive Surgery | August 15, 2019 | Volume: 144 | Issue: 5 | Pages: 949e-950e

10.1097/prs.0000000000006142 | PMID 31688779 Get It

Matching into Integrated Plastic Surgery: The Value of Research Fellowships
Rajesh, Aashish , Nashed, Mohammad, Vyas, Krishna S. , Asaad, Malke

Mayo Clinic

Plastic & Reconstructive Surgery | August 15, 2019 | Volume: 144 | Issue: 5 | Pages: 946e-947e

10.1097/prs.0000000000006138 | PMID 31425425 Get It

Putative mechanisms for spread and transformation of cutaneous T‐cell lymphoma to neurolymphomatosis
Puffer, Ross C. , Dyck, P. James B. , Paul, Pritikanta , Amrami, Kimberly K. , Spinner, Robert J. , Paul, Pritikanta , Broski, Stephen M.

Mayo Clinic

Muscle & Nerve | August 15, 2019 | Volume: 60 | Issue: 5 | Pages: No page available

10.1002/mus.26670 | PMID 31415100 Get It

Echo-Doppler Assessment of Left Filling Pressures in Adults With Repaired Tetralogy of Fallot
Miranda, William R. , Connolly, Heidi M. , Hagler, Donald J. , Oh, Jae K. , Egbe, Alexander C. , Taggart, Nathaniel W.

Mayo Clinic

Circulation: Cardiovascular Imaging | August 15, 2019 | Volume: 12 | Issue: 8 | Pages: No page available

10.1161/circimaging.119.009195 | PMID 31412722 Get It

Evaluation of treatment outcome in patients with acute-on-chronic liver failure using clinical scores
Alempijević, Tamara , Lalošević, Milica Stojković , Dragašević, Sanja , Jocic, Nevena, Baralić, Marko , Pavlović-Marković, Aleksandra, Alempijevic, Tamara , Stojkovic Lalosevic, Milica , Baralic, Marko , Dumic, Igor

Mayo Clinic

Srpski arhiv za celokupno lekarstvo | August 15, 2019 | Volume: 148 | Issue: 3-4 | Pages: 153-159

10.2298/sarh190511093m Get It

Introduction/Objective. Due to a very high mortality risk, acute-on-chronic liver failure (ACLF) patients require early identification and intensive treatment. Precise prediction is crucial for determining the urgency degree and therapy appropriateness, considering high mortality and multitude of clinical resources. The aim of our study was to determine the exact cut-off values of various prognostic scores in the prediction of morality of ACLF. Methods. This prospective study includes chronic liver disease (CLD) patients, admitted due to decompensation, that were subsequently diagnosed with ACLF at the Emergency unit. All patients were evaluated based on various prognostic scores, including Child?Pugh, MELD Na, MELD, SOFA, APACHE II, and CLIF C, which were calculated on admission. Results. Alcoholic liver disease (ALD) was the most common underlying CLD cause (77.9%), followed by viral (8.6%), autoimmune (7.7%), and other causes (5.8%). A total of 37.5% of the patients died at the end of the first month of treatment. Average values of Child?Pugh, MELD Na, MELD, SOFA, APACHE II, and CLIF C scores were significantly higher in patients who died compared to survivors (p < 0.05). CLIF C score showed the best performance with a cut-off value of 50.5, with a sensitivity of 94.9% and specificity of 40%. Conclusion. ACLF remains a condition with a high short-term mortality. Of all of the scores examined in our study, CLIF C proved to be the best scoring system for predicting short term and end of treatment mortality in patients with ACLF.
Two-Staged Implant-Based Breast Reconstruction: A Long-Term Outcome Study in a Young Population
Manrique, Oscar J. , Charafeddine, Ali H., Abu‐Ghname, Amjed , Banuelos, Joseph, Jacobson, Steven R., Martinez‐Jorge, Jorys, Nguyen, Minh-Doan T. , Harless, Christin A., Tran, Nho V. , Sharaf, Basel , Jakub, James W. , Charafeddine, Ali, Nguyen, Minh-Doan, Harless, Christin, Jakub, James W , Hieken, Tina J. , Degnim, Amy C. , Boughey, Judy C. , Sharaf, Basel A

Mayo Clinic

Medicina | August 15, 2019 | Volume: 55 | Issue: 8 | Pages: 481

10.3390/medicina55080481 | PMID 31416221 Get It

Background and objectives: Differences in patient anatomy and physiology exist between young and older patients undergoing breast reconstruction after mastectomy. Breast cancer has been described as being more aggressive, more likely to receive radiation, contralateral mastectomy, as well as bilateral reconstruction in young patients. Our purpose is to report long-term experience on two-staged implant-based breast reconstruction (IBR) in young females, with complication sub-analysis based on obesity and adjuvant radiation. Materials and Methods: Retrospective chart review of all consecutive young patients who underwent two-staged IBR at our institution, between 2000 and 2016, was performed. Patients between 15 and 40 years old with least 1-year follow-up were included. Univariate logistic regression models and receiver operating characteristic (ROC) curves were created. Results: Overall 594 breasts met our inclusion criteria. The mean age was 34 years, and the median follow-up was 29.6 months. Final IBR was achieved in 98% of breasts. Overall, 12% of breasts had complications, leading to explantations of 5% of the devices. Adjuvant radiation was followed by higher rates of total device explantations (p = 0.003), while obese patients had higher rates of total complications (p < 0.001). For each point increase in BMI, the odds of developing complications increased 8.1% (p < 0.001); the cutoff BMI to predict higher complications was 24.81 kg/m2. Conclusions: This population demonstrates high successful IBR completion and low explantation rates. These data suggest that obese women and those with planned adjuvant radiation deserve special counseling about their higher risk of complications.
Reflecting on shared decision making: A reflection‐quantification study
Kunneman, Marleen , LaVecchia, Christina M. , Ospina, Naykky Singh , Dabrh, Abd Moain Abu , Behnken, Emma , Wilson, Patrick M. , Hargraves, Ian , Yost, Kathleen J. , Frankel, Richard M. , Abu Dabrh, Abd Moain, Behnken, Emma M, Wilson, Patrick, Branda, Megan E. , Hargraves, Ian G, Abu Dabrh, Abd Moain , Singh Ospina, Naykky , Montori, Víctor M.

Mayo Clinic

Health Expectations | August 15, 2019 | Volume: 22 | Issue: 5 | Pages: 1165-1172

10.1111/hex.12953 | PMID 31414553 Get It

AbstractBackgroundReflecting (“stop‐and‐think”) before rating may help patients consider the quality of shared decision making (SDM) and mitigate ceiling/halo effects that limit the performance of self‐reported SDM measures.MethodsWe asked a diverse patient sample from the United States to reflect on their care before completing the 3‐item CollaboRATE SDM measure. Study 1 focused on rephrasing CollaboRATE items to promote reflection before each item. Study 2 used 5 open‐ended questions (about what went well and what could be improved upon, signs that the clinician understood the patient's situation, how the situation will be addressed, and why this treatment plan makes sense) to invite reflection before using the whole scale. A linear analogue scale assessed the extent to which the plan of care made sense to the patient.ResultsIn Study 1, 107 participants completed surveys (84% response rate), 43 (40%) rated a clinical decision of which 27 (63%) after responding to reflection questions. Adding reflection lowered CollaboRATE scores (“less” SDM) and reduced the proportion of patients giving maximum (ceiling) scores (not statistically significant). In Study 2, 103 of 212 responders (49%) fully completed the version containing reflection questions. Reflection did not significantly change the distribution of CollaboRATE scores or of top scores. Participants indicated high scores on the sense of their care plan (mean 9.7 out of 10, SD 0.79). This rating was weakly correlated with total CollaboRATE scores (rho = .4, P = .0001).ConclusionReflection‐before‐quantification interventions may not improve the performance of patient‐reported measures of SDM with substantial ceiling/halo effects.